nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—ABCB1—Mitomycin—urinary bladder cancer	0.161	0.229	CbGbCtD
SIMEPREVIR—SLCO1B1—Methotrexate—urinary bladder cancer	0.0761	0.109	CbGbCtD
SIMEPREVIR—ALB—Fluorouracil—urinary bladder cancer	0.0756	0.108	CbGbCtD
SIMEPREVIR—CYP3A4—Thiotepa—urinary bladder cancer	0.0729	0.104	CbGbCtD
SIMEPREVIR—ABCB1—Gemcitabine—urinary bladder cancer	0.0462	0.066	CbGbCtD
SIMEPREVIR—CYP1A2—Fluorouracil—urinary bladder cancer	0.0452	0.0646	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—urinary bladder cancer	0.0417	0.0595	CbGbCtD
SIMEPREVIR—CYP1A2—Etoposide—urinary bladder cancer	0.0377	0.0539	CbGbCtD
SIMEPREVIR—ABCB1—Cisplatin—urinary bladder cancer	0.0336	0.048	CbGbCtD
SIMEPREVIR—ABCB1—Etoposide—urinary bladder cancer	0.033	0.0471	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—urinary bladder cancer	0.0225	0.0321	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—urinary bladder cancer	0.0218	0.0311	CbGbCtD
SIMEPREVIR—CYP3A4—Etoposide—urinary bladder cancer	0.0198	0.0282	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—urinary bladder cancer	0.0135	0.0193	CbGbCtD
SIMEPREVIR—CTSS—prostate gland—urinary bladder cancer	0.00666	0.107	CbGeAlD
SIMEPREVIR—CYP1A2—urine—urinary bladder cancer	0.00638	0.103	CbGeAlD
SIMEPREVIR—CTSS—seminal vesicle—urinary bladder cancer	0.00563	0.0904	CbGeAlD
SIMEPREVIR—CTSS—smooth muscle tissue—urinary bladder cancer	0.00471	0.0757	CbGeAlD
SIMEPREVIR—CYP3A4—urine—urinary bladder cancer	0.00462	0.0742	CbGeAlD
SIMEPREVIR—CTSS—renal system—urinary bladder cancer	0.00454	0.0729	CbGeAlD
SIMEPREVIR—CTSS—urethra—urinary bladder cancer	0.00446	0.0716	CbGeAlD
SIMEPREVIR—CTSS—female reproductive system—urinary bladder cancer	0.00363	0.0584	CbGeAlD
SIMEPREVIR—CTSS—vagina—urinary bladder cancer	0.00329	0.0528	CbGeAlD
SIMEPREVIR—SLCO1B1—renal system—urinary bladder cancer	0.00294	0.0472	CbGeAlD
SIMEPREVIR—Anaemia—Valrubicin—urinary bladder cancer	0.00284	0.0235	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Thiotepa—urinary bladder cancer	0.00268	0.0222	CcSEcCtD
SIMEPREVIR—Myalgia—Valrubicin—urinary bladder cancer	0.00262	0.0217	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Thiotepa—urinary bladder cancer	0.00258	0.0213	CcSEcCtD
SIMEPREVIR—SLCO1B1—female reproductive system—urinary bladder cancer	0.00235	0.0378	CbGeAlD
SIMEPREVIR—Infection—Carboplatin—urinary bladder cancer	0.00231	0.0191	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00229	0.0189	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Gemcitabine—urinary bladder cancer	0.00226	0.0187	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Gemcitabine—urinary bladder cancer	0.00217	0.018	CcSEcCtD
SIMEPREVIR—CTSS—lymph node—urinary bladder cancer	0.00213	0.0341	CbGeAlD
SIMEPREVIR—Anaemia—Mitomycin—urinary bladder cancer	0.00196	0.0162	CcSEcCtD
SIMEPREVIR—Asthenia—Valrubicin—urinary bladder cancer	0.0018	0.0149	CcSEcCtD
SIMEPREVIR—Pruritus—Valrubicin—urinary bladder cancer	0.00178	0.0147	CcSEcCtD
SIMEPREVIR—Photosensitivity—Fluorouracil—urinary bladder cancer	0.00167	0.0138	CcSEcCtD
SIMEPREVIR—Rash—Valrubicin—urinary bladder cancer	0.00158	0.0131	CcSEcCtD
SIMEPREVIR—Dermatitis—Valrubicin—urinary bladder cancer	0.00158	0.0131	CcSEcCtD
SIMEPREVIR—Headache—Valrubicin—urinary bladder cancer	0.00157	0.013	CcSEcCtD
SIMEPREVIR—CYP1A2—renal system—urinary bladder cancer	0.00156	0.0251	CbGeAlD
SIMEPREVIR—Dyspnoea—Mitomycin—urinary bladder cancer	0.00154	0.0128	CcSEcCtD
SIMEPREVIR—Nausea—Valrubicin—urinary bladder cancer	0.00149	0.0123	CcSEcCtD
SIMEPREVIR—Fatigue—Mitomycin—urinary bladder cancer	0.00149	0.0123	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00129	0.0107	CcSEcCtD
SIMEPREVIR—Asthenia—Mitomycin—urinary bladder cancer	0.00124	0.0103	CcSEcCtD
SIMEPREVIR—ABCB1—prostate gland—urinary bladder cancer	0.00117	0.0189	CbGeAlD
SIMEPREVIR—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00116	0.00956	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Methotrexate—urinary bladder cancer	0.00115	0.00955	CcSEcCtD
SIMEPREVIR—CYP3A4—renal system—urinary bladder cancer	0.00113	0.0182	CbGeAlD
SIMEPREVIR—ALB—lymph node—urinary bladder cancer	0.00111	0.0179	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.0011	0.00914	CcSEcCtD
SIMEPREVIR—Rash—Mitomycin—urinary bladder cancer	0.00109	0.00903	CcSEcCtD
SIMEPREVIR—Dermatitis—Mitomycin—urinary bladder cancer	0.00109	0.00902	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00109	0.00899	CcSEcCtD
SIMEPREVIR—Headache—Mitomycin—urinary bladder cancer	0.00108	0.00897	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Epirubicin—urinary bladder cancer	0.00108	0.00894	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Epirubicin—urinary bladder cancer	0.00104	0.00859	CcSEcCtD
SIMEPREVIR—Nausea—Mitomycin—urinary bladder cancer	0.00103	0.00851	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00101	0.00838	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Doxorubicin—urinary bladder cancer	0.000999	0.00827	CcSEcCtD
SIMEPREVIR—ABCB1—seminal vesicle—urinary bladder cancer	0.000993	0.016	CbGeAlD
SIMEPREVIR—Anaemia—Thiotepa—urinary bladder cancer	0.000986	0.00816	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Doxorubicin—urinary bladder cancer	0.000961	0.00795	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000929	0.00769	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000927	0.00767	CcSEcCtD
SIMEPREVIR—Myalgia—Thiotepa—urinary bladder cancer	0.000908	0.00751	CcSEcCtD
SIMEPREVIR—CYP3A4—female reproductive system—urinary bladder cancer	0.000906	0.0145	CbGeAlD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000902	0.00746	CcSEcCtD
SIMEPREVIR—Photosensitivity—Methotrexate—urinary bladder cancer	0.000868	0.00718	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000866	0.00716	CcSEcCtD
SIMEPREVIR—Infection—Thiotepa—urinary bladder cancer	0.000865	0.00716	CcSEcCtD
SIMEPREVIR—ABCB1—epithelium—urinary bladder cancer	0.000863	0.0139	CbGeAlD
SIMEPREVIR—Skin disorder—Thiotepa—urinary bladder cancer	0.000845	0.007	CcSEcCtD
SIMEPREVIR—Anaemia—Gemcitabine—urinary bladder cancer	0.000829	0.00686	CcSEcCtD
SIMEPREVIR—Anaemia—Fluorouracil—urinary bladder cancer	0.000815	0.00675	CcSEcCtD
SIMEPREVIR—Photosensitivity—Epirubicin—urinary bladder cancer	0.000812	0.00672	CcSEcCtD
SIMEPREVIR—ABCB1—renal system—urinary bladder cancer	0.0008	0.0129	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000793	0.00656	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000793	0.00656	CcSEcCtD
SIMEPREVIR—ABCB1—urethra—urinary bladder cancer	0.000786	0.0126	CbGeAlD
SIMEPREVIR—Anaemia—Cisplatin—urinary bladder cancer	0.000773	0.0064	CcSEcCtD
SIMEPREVIR—Myalgia—Gemcitabine—urinary bladder cancer	0.000764	0.00632	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000758	0.00628	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000751	0.00622	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—urinary bladder cancer	0.000751	0.00622	CcSEcCtD
SIMEPREVIR—Myalgia—Fluorouracil—urinary bladder cancer	0.000751	0.00621	CcSEcCtD
SIMEPREVIR—Fatigue—Thiotepa—urinary bladder cancer	0.00075	0.00621	CcSEcCtD
SIMEPREVIR—Constipation—Thiotepa—urinary bladder cancer	0.000744	0.00616	CcSEcCtD
SIMEPREVIR—Infection—Gemcitabine—urinary bladder cancer	0.000727	0.00602	CcSEcCtD
SIMEPREVIR—Infection—Fluorouracil—urinary bladder cancer	0.000715	0.00592	CcSEcCtD
SIMEPREVIR—Myalgia—Cisplatin—urinary bladder cancer	0.000712	0.00589	CcSEcCtD
SIMEPREVIR—Skin disorder—Gemcitabine—urinary bladder cancer	0.000711	0.00589	CcSEcCtD
SIMEPREVIR—Anaemia—Etoposide—urinary bladder cancer	0.000708	0.00586	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000707	0.00585	CcSEcCtD
SIMEPREVIR—Infection—Cisplatin—urinary bladder cancer	0.000678	0.00561	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000667	0.00552	CcSEcCtD
SIMEPREVIR—Skin disorder—Cisplatin—urinary bladder cancer	0.000663	0.00549	CcSEcCtD
SIMEPREVIR—Insomnia—Gemcitabine—urinary bladder cancer	0.000662	0.00548	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000656	0.00543	CcSEcCtD
SIMEPREVIR—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000653	0.0054	CcSEcCtD
SIMEPREVIR—Insomnia—Fluorouracil—urinary bladder cancer	0.000651	0.00539	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000648	0.00536	CcSEcCtD
SIMEPREVIR—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000642	0.00531	CcSEcCtD
SIMEPREVIR—ABCB1—female reproductive system—urinary bladder cancer	0.000641	0.0103	CbGeAlD
SIMEPREVIR—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000632	0.00523	CcSEcCtD
SIMEPREVIR—Fatigue—Gemcitabine—urinary bladder cancer	0.000631	0.00522	CcSEcCtD
SIMEPREVIR—Constipation—Gemcitabine—urinary bladder cancer	0.000626	0.00518	CcSEcCtD
SIMEPREVIR—Asthenia—Thiotepa—urinary bladder cancer	0.000624	0.00517	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000622	0.00515	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000621	0.00514	CcSEcCtD
SIMEPREVIR—Infection—Etoposide—urinary bladder cancer	0.000621	0.00514	CcSEcCtD
SIMEPREVIR—Pruritus—Thiotepa—urinary bladder cancer	0.000616	0.0051	CcSEcCtD
SIMEPREVIR—Dyspnoea—Cisplatin—urinary bladder cancer	0.000608	0.00504	CcSEcCtD
SIMEPREVIR—Skin disorder—Etoposide—urinary bladder cancer	0.000607	0.00503	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000601	0.00497	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000589	0.00488	CcSEcCtD
SIMEPREVIR—ABCB1—vagina—urinary bladder cancer	0.00058	0.00931	CbGeAlD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000562	0.00466	CcSEcCtD
SIMEPREVIR—Dyspnoea—Etoposide—urinary bladder cancer	0.000557	0.00461	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000555	0.0046	CcSEcCtD
SIMEPREVIR—Rash—Thiotepa—urinary bladder cancer	0.000549	0.00454	CcSEcCtD
SIMEPREVIR—Dermatitis—Thiotepa—urinary bladder cancer	0.000548	0.00454	CcSEcCtD
SIMEPREVIR—Headache—Thiotepa—urinary bladder cancer	0.000545	0.00451	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00054	0.00447	CcSEcCtD
SIMEPREVIR—Fatigue—Etoposide—urinary bladder cancer	0.000539	0.00446	CcSEcCtD
SIMEPREVIR—Constipation—Etoposide—urinary bladder cancer	0.000535	0.00442	CcSEcCtD
SIMEPREVIR—Asthenia—Gemcitabine—urinary bladder cancer	0.000525	0.00435	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00052	0.00431	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00052	0.0043	CcSEcCtD
SIMEPREVIR—Pruritus—Gemcitabine—urinary bladder cancer	0.000518	0.00429	CcSEcCtD
SIMEPREVIR—Nausea—Thiotepa—urinary bladder cancer	0.000517	0.00428	CcSEcCtD
SIMEPREVIR—Pruritus—Fluorouracil—urinary bladder cancer	0.000509	0.00422	CcSEcCtD
SIMEPREVIR—Asthenia—Cisplatin—urinary bladder cancer	0.00049	0.00405	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000481	0.00398	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000475	0.00393	CcSEcCtD
SIMEPREVIR—Rash—Gemcitabine—urinary bladder cancer	0.000462	0.00382	CcSEcCtD
SIMEPREVIR—Dermatitis—Gemcitabine—urinary bladder cancer	0.000461	0.00382	CcSEcCtD
SIMEPREVIR—Headache—Gemcitabine—urinary bladder cancer	0.000459	0.0038	CcSEcCtD
SIMEPREVIR—Rash—Fluorouracil—urinary bladder cancer	0.000454	0.00376	CcSEcCtD
SIMEPREVIR—Dermatitis—Fluorouracil—urinary bladder cancer	0.000453	0.00375	CcSEcCtD
SIMEPREVIR—Headache—Fluorouracil—urinary bladder cancer	0.000451	0.00373	CcSEcCtD
SIMEPREVIR—Asthenia—Etoposide—urinary bladder cancer	0.000449	0.00371	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000445	0.00368	CcSEcCtD
SIMEPREVIR—Pruritus—Etoposide—urinary bladder cancer	0.000442	0.00366	CcSEcCtD
SIMEPREVIR—Nausea—Gemcitabine—urinary bladder cancer	0.000435	0.0036	CcSEcCtD
SIMEPREVIR—Rash—Cisplatin—urinary bladder cancer	0.00043	0.00356	CcSEcCtD
SIMEPREVIR—Dermatitis—Cisplatin—urinary bladder cancer	0.00043	0.00356	CcSEcCtD
SIMEPREVIR—Nausea—Fluorouracil—urinary bladder cancer	0.000428	0.00354	CcSEcCtD
SIMEPREVIR—Anaemia—Methotrexate—urinary bladder cancer	0.000424	0.00351	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000411	0.0034	CcSEcCtD
SIMEPREVIR—Nausea—Cisplatin—urinary bladder cancer	0.000405	0.00335	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—urinary bladder cancer	0.000397	0.00328	CcSEcCtD
SIMEPREVIR—Rash—Etoposide—urinary bladder cancer	0.000394	0.00326	CcSEcCtD
SIMEPREVIR—Dermatitis—Etoposide—urinary bladder cancer	0.000394	0.00326	CcSEcCtD
SIMEPREVIR—Headache—Etoposide—urinary bladder cancer	0.000392	0.00324	CcSEcCtD
SIMEPREVIR—Myalgia—Methotrexate—urinary bladder cancer	0.000391	0.00323	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000388	0.00321	CcSEcCtD
SIMEPREVIR—ABCB1—lymph node—urinary bladder cancer	0.000375	0.00602	CbGeAlD
SIMEPREVIR—Infection—Methotrexate—urinary bladder cancer	0.000372	0.00308	CcSEcCtD
SIMEPREVIR—Nausea—Etoposide—urinary bladder cancer	0.000371	0.00307	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—urinary bladder cancer	0.000367	0.00304	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—urinary bladder cancer	0.000366	0.00303	CcSEcCtD
SIMEPREVIR—Skin disorder—Methotrexate—urinary bladder cancer	0.000364	0.00301	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000363	0.003	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—urinary bladder cancer	0.000348	0.00288	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000341	0.00282	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—urinary bladder cancer	0.00034	0.00282	CcSEcCtD
SIMEPREVIR—Insomnia—Methotrexate—urinary bladder cancer	0.000339	0.0028	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—urinary bladder cancer	0.000338	0.0028	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000336	0.00278	CcSEcCtD
SIMEPREVIR—Dyspnoea—Methotrexate—urinary bladder cancer	0.000334	0.00276	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000323	0.00268	CcSEcCtD
SIMEPREVIR—Fatigue—Methotrexate—urinary bladder cancer	0.000323	0.00267	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—urinary bladder cancer	0.000322	0.00267	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000319	0.00264	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—urinary bladder cancer	0.000317	0.00262	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—urinary bladder cancer	0.000315	0.00261	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—urinary bladder cancer	0.000312	0.00259	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000303	0.0025	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—urinary bladder cancer	0.000302	0.0025	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—urinary bladder cancer	0.0003	0.00248	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000295	0.00245	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—urinary bladder cancer	0.000293	0.00243	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000289	0.00239	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00028	0.00232	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—urinary bladder cancer	0.00028	0.00231	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—urinary bladder cancer	0.000277	0.00229	CcSEcCtD
SIMEPREVIR—Asthenia—Methotrexate—urinary bladder cancer	0.000269	0.00222	CcSEcCtD
SIMEPREVIR—Pruritus—Methotrexate—urinary bladder cancer	0.000265	0.00219	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—urinary bladder cancer	0.000251	0.00208	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—urinary bladder cancer	0.000248	0.00205	CcSEcCtD
SIMEPREVIR—Rash—Methotrexate—urinary bladder cancer	0.000236	0.00195	CcSEcCtD
SIMEPREVIR—Dermatitis—Methotrexate—urinary bladder cancer	0.000236	0.00195	CcSEcCtD
SIMEPREVIR—Headache—Methotrexate—urinary bladder cancer	0.000235	0.00194	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—urinary bladder cancer	0.000233	0.00193	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—urinary bladder cancer	0.000229	0.0019	CcSEcCtD
SIMEPREVIR—Nausea—Methotrexate—urinary bladder cancer	0.000222	0.00184	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—urinary bladder cancer	0.000221	0.00183	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—urinary bladder cancer	0.000221	0.00183	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—urinary bladder cancer	0.00022	0.00182	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—urinary bladder cancer	0.000208	0.00172	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—urinary bladder cancer	0.000204	0.00169	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—urinary bladder cancer	0.000204	0.00169	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—urinary bladder cancer	0.000203	0.00168	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—urinary bladder cancer	0.000193	0.00159	CcSEcCtD
SIMEPREVIR—CTSS—Innate Immune System—PTEN—urinary bladder cancer	0.000127	0.00109	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000127	0.00109	CbGpPWpGaD
SIMEPREVIR—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000125	0.00107	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000125	0.00107	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000123	0.00106	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.000122	0.00105	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—PTEN—urinary bladder cancer	0.000122	0.00104	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—FGFR3—urinary bladder cancer	0.000122	0.00104	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—EP300—urinary bladder cancer	0.000121	0.00104	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000121	0.00103	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000121	0.00103	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00012	0.00103	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—SRC—urinary bladder cancer	0.000118	0.00101	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000117	0.001	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000117	0.001	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP4B1—urinary bladder cancer	0.000117	0.000999	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000114	0.000979	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000113	0.000969	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—SRC—urinary bladder cancer	0.000113	0.000969	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000112	0.000958	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SLC19A1—urinary bladder cancer	0.00011	0.000943	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00011	0.000937	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000109	0.000935	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000109	0.000929	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PRSS3—urinary bladder cancer	0.000107	0.000919	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000106	0.00091	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000105	0.0009	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000105	0.000898	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000105	0.000896	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000104	0.000894	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CREBBP—urinary bladder cancer	0.000104	0.000888	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—EGFR—urinary bladder cancer	0.000103	0.000885	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CDH1—urinary bladder cancer	0.000103	0.000881	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000103	0.00088	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000103	0.00088	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000102	0.000872	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—EGFR—urinary bladder cancer	9.92e-05	0.000849	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	9.8e-05	0.000838	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.8e-05	0.000838	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—KRAS—urinary bladder cancer	9.76e-05	0.000836	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	9.75e-05	0.000835	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.72e-05	0.000832	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.62e-05	0.000823	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—KRAS—urinary bladder cancer	9.38e-05	0.000802	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.25e-05	0.000792	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—urinary bladder cancer	9.25e-05	0.000792	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	8.96e-05	0.000767	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.93e-05	0.000764	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.84e-05	0.000756	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ERBB2—urinary bladder cancer	8.68e-05	0.000743	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.61e-05	0.000737	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	8.59e-05	0.000735	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTZ1—urinary bladder cancer	8.54e-05	0.000731	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	8.33e-05	0.000713	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—HRAS—urinary bladder cancer	8.3e-05	0.00071	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.26e-05	0.000707	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.25e-05	0.000706	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.18e-05	0.0007	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.14e-05	0.000697	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.11e-05	0.000694	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTO2—urinary bladder cancer	8.1e-05	0.000693	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NAT1—urinary bladder cancer	8.1e-05	0.000693	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HRAS—urinary bladder cancer	7.97e-05	0.000682	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.96e-05	0.000682	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	7.96e-05	0.000681	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL2—urinary bladder cancer	7.87e-05	0.000674	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	7.76e-05	0.000664	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.53e-05	0.000644	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.48e-05	0.00064	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CDKN1A—urinary bladder cancer	7.42e-05	0.000635	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.42e-05	0.000635	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PTEN—urinary bladder cancer	7.41e-05	0.000634	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—UGT2B7—urinary bladder cancer	7.4e-05	0.000634	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	7.13e-05	0.00061	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.11e-05	0.000608	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTO2—urinary bladder cancer	7.09e-05	0.000607	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NAT1—urinary bladder cancer	7.09e-05	0.000607	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—EP300—urinary bladder cancer	7.06e-05	0.000604	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.02e-05	0.000601	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.92e-05	0.000592	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.88e-05	0.000589	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—SRC—urinary bladder cancer	6.87e-05	0.000588	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.82e-05	0.000584	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	6.7e-05	0.000574	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP4B1—urinary bladder cancer	6.67e-05	0.000571	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	6.53e-05	0.000559	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.49e-05	0.000555	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IFNA2—urinary bladder cancer	6.36e-05	0.000544	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC19A1—urinary bladder cancer	6.3e-05	0.000539	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	6.21e-05	0.000531	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	6.21e-05	0.000531	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.17e-05	0.000528	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PRSS3—urinary bladder cancer	6.14e-05	0.000525	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.03e-05	0.000516	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	6.02e-05	0.000515	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—EGFR—urinary bladder cancer	6.02e-05	0.000515	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.97e-05	0.000511	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.95e-05	0.000509	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.93e-05	0.000507	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.84e-05	0.0005	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.82e-05	0.000498	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—KRAS—urinary bladder cancer	5.69e-05	0.000487	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.66e-05	0.000485	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.66e-05	0.000485	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.64e-05	0.000482	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.57e-05	0.000477	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.52e-05	0.000472	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	5.48e-05	0.000469	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.38e-05	0.00046	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.26e-05	0.00045	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.18e-05	0.000443	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.09e-05	0.000435	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.08e-05	0.000434	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	5e-05	0.000428	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.92e-05	0.000421	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TYMP—urinary bladder cancer	4.91e-05	0.00042	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.85e-05	0.000415	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.84e-05	0.000414	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HRAS—urinary bladder cancer	4.83e-05	0.000414	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.78e-05	0.000409	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.71e-05	0.000403	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.71e-05	0.000403	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.66e-05	0.000399	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.61e-05	0.000395	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PLAU—urinary bladder cancer	4.51e-05	0.000386	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NAT2—urinary bladder cancer	4.44e-05	0.00038	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.4e-05	0.000377	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.37e-05	0.000374	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.37e-05	0.000374	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.3e-05	0.000368	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.29e-05	0.000367	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.23e-05	0.000362	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.22e-05	0.000361	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	4.17e-05	0.000357	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.13e-05	0.000353	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.04e-05	0.000346	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4e-05	0.000342	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.93e-05	0.000336	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.9e-05	0.000334	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.89e-05	0.000333	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	3.88e-05	0.000332	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	3.83e-05	0.000328	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	3.83e-05	0.000328	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—RRM2—urinary bladder cancer	3.83e-05	0.000328	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—CREBBP—urinary bladder cancer	3.72e-05	0.000318	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IGF1—urinary bladder cancer	3.67e-05	0.000314	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	3.67e-05	0.000314	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	3.61e-05	0.000309	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.6e-05	0.000308	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—HPGDS—urinary bladder cancer	3.55e-05	0.000304	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ENO2—urinary bladder cancer	3.55e-05	0.000304	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.53e-05	0.000302	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.46e-05	0.000296	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.44e-05	0.000295	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTT1—urinary bladder cancer	3.44e-05	0.000294	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.43e-05	0.000294	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.4e-05	0.000291	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	3.39e-05	0.00029	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.39e-05	0.00029	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—RHOA—urinary bladder cancer	3.37e-05	0.000288	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.36e-05	0.000287	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.31e-05	0.000283	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.3e-05	0.000282	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.22e-05	0.000276	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.11e-05	0.000266	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.11e-05	0.000266	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.1e-05	0.000266	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.01e-05	0.000258	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NQO1—urinary bladder cancer	2.86e-05	0.000245	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—urinary bladder cancer	2.82e-05	0.000242	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.82e-05	0.000241	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.77e-05	0.000237	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	2.75e-05	0.000235	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.68e-05	0.000229	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.65e-05	0.000227	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	2.64e-05	0.000226	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—EP300—urinary bladder cancer	2.53e-05	0.000217	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.5e-05	0.000214	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.48e-05	0.000212	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.48e-05	0.000212	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.47e-05	0.000211	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SRC—urinary bladder cancer	2.46e-05	0.000211	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.42e-05	0.000207	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.41e-05	0.000206	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.39e-05	0.000205	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—urinary bladder cancer	2.38e-05	0.000204	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.37e-05	0.000203	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.31e-05	0.000197	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TYMS—urinary bladder cancer	2.22e-05	0.00019	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOR1—urinary bladder cancer	2.19e-05	0.000188	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—urinary bladder cancer	2.19e-05	0.000188	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.16e-05	0.000185	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GPX1—urinary bladder cancer	2.1e-05	0.00018	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.09e-05	0.000179	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.07e-05	0.000177	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ERCC2—urinary bladder cancer	2.06e-05	0.000176	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—urinary bladder cancer	2.04e-05	0.000175	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2e-05	0.000171	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.94e-05	0.000166	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.94e-05	0.000166	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—MTHFR—urinary bladder cancer	1.94e-05	0.000166	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.92e-05	0.000164	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.92e-05	0.000164	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.91e-05	0.000164	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.91e-05	0.000164	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	1.89e-05	0.000161	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.86e-05	0.000159	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000157	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—urinary bladder cancer	1.81e-05	0.000155	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	0.000154	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—EP300—urinary bladder cancer	1.8e-05	0.000154	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—HRAS—urinary bladder cancer	1.73e-05	0.000148	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	0.000145	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.69e-05	0.000145	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.67e-05	0.000143	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.61e-05	0.000138	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPARG—urinary bladder cancer	1.57e-05	0.000134	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.55e-05	0.000133	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.54e-05	0.000132	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.53e-05	0.000131	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.53e-05	0.000131	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CREBBP—urinary bladder cancer	1.51e-05	0.000129	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.47e-05	0.000126	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.44e-05	0.000123	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000118	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	0.000116	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.000113	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.29e-05	0.00011	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.000106	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.2e-05	0.000102	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	0.000101	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	0.000101	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.13e-05	9.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	9.52e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.1e-05	9.4e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	9.26e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—urinary bladder cancer	1.08e-05	9.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	9.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.05e-05	8.95e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—EP300—urinary bladder cancer	1.03e-05	8.79e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.44e-06	8.08e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—EP300—urinary bladder cancer	9e-06	7.7e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.64e-06	7.39e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.48e-06	7.25e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.14e-06	6.97e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.53e-06	6.45e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.19e-06	6.15e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.67e-06	5.71e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.81e-06	4.98e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.55e-06	4.75e-05	CbGpPWpGaD
